Eagle Pharmaceuticals
EGRX
A$5.66
Share price
0.00%
Change (1 day)
-26.65%
Change (1 year)
Categories
EPS for Eagle Pharmaceuticals (EGRX)
EPS in 2023 (TTM): A$1.33
According to Eagle Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A$1.41. In 2022 the company made an earnings per share (EPS) of A$4.33 an increase over its 2021 EPS that were of A-$1.01.
EPS history for Eagle Pharmaceuticals from 2014 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | A$1.33 | -69.3% |
| 2022 | A$4.33 | -527.27% |
| 2021 | A-$1.01 | |
| 2019 | A$1.58 | -52.75% |
| 2018 | A$3.35 | -36.63% |
| 2017 | A$5.28 | -35.09% |
| 2016 | A$8.13 | 1792.86% |
| 2015 | A$0.43 | -117.39% |
| 2014 | A-$2.47 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | A$13.92 | 885.62% | 🇺🇸 USA |
 GlaxoSmithKline GSK | A$2.39 | 69.54% | 🇬🇧 UK |
 Novartis NVS | A$9.87 | 598.91% | 🇨🇭 Switzerland |
 Teva Pharmaceutical Industries TEVA | A-$1.75 | -223.91% | 🇮🇱 Israel |
 Amgen AMGN | A$16.96 | 1,101.09% | 🇺🇸 USA |
 Eli Lilly LLY | A$18.96 | 1,243.04% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | A$4.11 | 191.30% | 🇺🇸 USA |